Tag: ADC
Sorrento Announces Positive Results From Its License Partner, Kelun, on a...
A166 (ASCO Abstract #1024) is a third generation antibody drug conjugate (ADC) against HER2-positive breast cancer with Levena’s proprietary tubulin inhibitor Duo-5 toxin,...
MacroGenics Announces Preliminary Clinical Results from Phase 1 Study of MGC018...
Dose escalation: anti-tumor activity observed in melanoma (including one confirmed partial response) and in mCRPC patientsCohort expansion in mCRPC: 11/22 (50%) patients have...
DENSO ADC Showcases BHT-M80 Terminal at Virtual ProMat DX
LONG BEACH, Calif., April 02, 2021 (GLOBE NEWSWIRE) -- DENSO ADC, one of the world’s largest manufacturers of automatic identification and data...